WhiteOak Capital Pharma and Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.28% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Other Info
Fund Overview
Rating
Not Rated
Minimum Investment
₹500
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹1003 Cr
Created on
2 Feb 2024
Fund Ranking
#
/ 19 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
14.9%
1 Year
12.9%
3 Year (CAGR)
-
All Time (CAGR)
18.7%
Category Return
6 Month
10.9%
1 Year
8.5%
3 Year (CAGR)
18.8%
All Time (CAGR)
16.8%
Asset Allocation
Equity
91.4%
Debt
8.0%
Other
0.5%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
3.47%
Apollo Hospitals Enterprise
0.19%
Aurobindo Pharma
1.93%
Aurobindo Pharma
1.44%
Bharat Parenterals
0.09%
Fund Information
Expense Ratio
2.74%
Exit Load
No Exit Load
Lock-In Period
No Lock-In
Managed By
Piyush Baranwal
Jan 2024 - Present
Ramesh Mantri
Jan 2024 - Present
Dheeresh Pathak
Jan 2024 - Present
Naitik Shah
April 2024 - Present
Trupti Agrawal
May 2025 - Present
Ashish Agrawal
Jan 2025 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.00
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
0.00
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
0.00
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.